• Mashup Score: 4

    Airway epithelial injury is thought to be a key event in the pathogenesis of chronic lung allograft dysfunction (CLAD). We investigated whether markers of epithelial activity and injury in bronchoalveolar lavage fluid (BAL) correlate with CLAD diagnosis and major CLAD phenotypes: bronchiolitis obliterans syndrome (BOS) vs restrictive allograft syndrome (RAS)-related phenotypes (including RAS, mixed phenotype, and all other patients with RAS-like opacities).

    Tweet Tweets with this article
    • Exciting findings #LungTransplant research! 🫁 Study reveals enhanced airway epithelial mucins & cell death markers in CLAD patients' bronchoalveolar lavage. These markers can differentiate CLAD phenotypes & predict post-CLAD outcome. 🌟 🔗https://t.co/KIw4XbdN3y

  • Mashup Score: 0

    This website uses cookies to ensure the best possible web experience. By continuing and using the site, you consent to the use of cookies. If you wish to disable them or to learn more about how we use cookies, please view our Cookies Policy.   Modernizing Your Transplant Program with an Integrated…

    Tweet Tweets with this article
    • 📅🫁 Next week: join #ISHLT + #LungBioengineering for a webinar on how to Modernize your #LungTransplant Program with an Integrated #EVLP Service. The webinar is free thanks to Lung Bioengineering, and will be viewable ondemand if you can't attend live. 🔗https://t.co/fGjaAZi0JF https://t.co/Kq5wpZUH3P

  • Mashup Score: 1

    Program Directors Program Directors Innovation Director: Marcelo Cypel Marcelo Cypel is a Staff Thoracic Surgeon at University Health Network (UHN) and Professor of Surgery at the University of Toronto. He is the Surgical Director of the Ajmera Transplant Center and the director of the ECLS program at UHN. He…

    Tweet Tweets with this article
    • Call For Abstracts. The AATS Mechanical Support and Thoracic #Transplantation Summit will be held June 9-10 in Toronto. Submit your research today at https://t.co/xuJD4D7BRF #ECMO #lungtransplant #LVAD https://t.co/pvCVftTtGT